VP Development and Scientific Affairs
PharmaLex
Mark heads the product development and regulatory affairs team for PharmaLex US, part of a global strategic, regulatory, and quality consultancy. His expertise includes clinical and regulatory strategy, as well as program, project, and portfolio management for drug development in multinationals, ventures, and with the NIH, and has co-authored over 100 peer-reviewed publications. He has over 25 years of experience including small molecules, biologics, biosimilars, and medical devices across multiple therapy areas.
Disclosure information not submitted.
Tuesday, September 13, 2022
2:00 PM – 3:00 PM MST